A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)

Clinical trial NCT04679103 · COMPLETED

Trial details

NCT number: NCT04679103
Sponsor: AO GENERIUM
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2018-05-03
Primary completion: 2020-04-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.